Resmed Inc [RMD] stock is trading at $236.17, down -0.10%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RMD shares have gain 3.27% over the last week, with a monthly amount drifted -2.17%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Resmed Inc [NYSE: RMD] stock has seen the most recent analyst activity on December 13, 2024, when Stifel initiated its Hold rating and assigned the stock a price target of $250. Previously, Robert W. Baird started tracking the stock with Outperform rating on September 24, 2024, and set its price target to $280. On September 18, 2024, downgrade downgraded it’s rating to Underperform but maintained its price target of $180 on the stock. Needham downgraded its rating to a Hold. Oppenheimer downgraded its rating to a Perform. Citigroup downgraded its rating to Neutral for this stock on June 24, 2024.
Resmed Inc [RMD] stock has fluctuated between $166.90 and $260.49 over the past year. Currently, Wall Street analysts expect the stock to reach $233.5 within the next 12 months. Resmed Inc [NYSE: RMD] shares were valued at $236.17 at the most recent close of the market. An investor can expect a potential drop of -1.13% based on the average RMD price forecast.
Analyzing the RMD fundamentals
Resmed Inc [NYSE:RMD] reported sales of 4.81B for the trailing twelve months, which represents a growth of 11.08%. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.23 and Total Capital is 0.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 233.39 points at the first support level, and at 230.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 238.08, and for the 2nd resistance point, it is at 239.98.
Ratios To Look Out For
For context, Resmed Inc’s Current Ratio is 2.92. In addition, the Quick Ratio stands at 1.91 and the Cash Ratio stands at 0.47. Considering the valuation of this stock, the price to sales ratio is 7.21, the price to book ratio is 6.67 and price to earnings (TTM) ratio is 31.31.
Transactions by insiders
Recent insider trading involved Sandercock Brett, Officer, that happened on Jan 08 ’25 when 1000.0 shares were purchased. Director, FARRELL PETER C completed a deal on Jan 02 ’25 to sell 2000.0 shares. Meanwhile, Global General Counsel Rider Michael J sold 75.0 shares on Jan 02 ’25.
